Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report) was the target of a significant increase in short interest in December. As of December 15th, there was short interest totalling 18,150,000 ...

Most experts seem to be predicting the S&P 500 will advance around 9% or 10% in the coming year. But there's a good chance ...

The index fund boasts a robust, 22.1% annualized return over the past five years – the top return of all infrastructure funds ...

Switzerland should not set rules for its banking sector that put it at a disadvantage, UBS CEO Sergio Ermotti was quoted as ...

UBS analyst Wei Xiong maintained a Hold rating on Vipshop (VIPS – Research Report) today and set a price target of $15.00. The company’s shares ...

UBS Group reiterated their buy rating on shares of ON (NYSE:ONON – Free Report) in a research note published on Friday,Benzinga reports. They currently have a $63.00 price objective on the stock.

Presentation Operator Good day, everyone, and welcome to the Cintas Corporation Announces Fiscal 2025 Second Quarter Results ...

While global stock markets have been on a pretty good run over ... recently published by UBS. At the top of that report was data showing that between 2015 and 2024, total billionaire wealth ...

UBS analyst Graham Doyle maintained a Hold rating on Koninklijke Philips N.V. (0LNG – Research Report) today and set a price target of €26.50.

Presentation Operator Thank you for standing by, and welcome to Micron Technologies Fiscal First Quarter 2025 Financial ...

APi Group's solid demand trend is due to a $3.5 billion backlog, robust end markets, and a promising M&A pipeline. See why we are reaffirming APG stock as a buy.

UBS initiated research coverage on shares of two major European football clubs, Manchester United (NYSE:MANU) and Juventus, with contrasting perspectives. The financial services firm sees a positive ...